Pacific Biosciences of California, Inc. (PACB)
收市後：
| 前收市價 | 8.94 |
| 開市 | 8.82 |
| 買盤 | 8.40 x 900 |
| 賣出價 | 8.85 x 900 |
| 今日波幅 | 8.42 - 8.93 |
| 52 週波幅 | 4.97 - 14.55 |
| 成交量 | |
| 平均成交量 | 3,583,722 |
| 市值 | 2.12B |
| Beta 值 (5 年，每月) | 1.64 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.35 |
| 業績公佈日 | 2023年11月06日 - 2023年11月10日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 15.58 |
Insider Monkey10 DNA Stocks Billionaires Are Loading Up On
In this article, we discuss 10 DNA stocks that billionaires love. If you want to skip our detailed analysis of the DNA market, head over to 5 DNA Stocks Billionaires Are Loading Up On. Genomics is the study of a complete set of DNA within an organism. The global genomics market was worth $28.39 billion […]
Insider MonkeyPacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2023 Earnings Call Transcript
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2023 Earnings Call Transcript May 2, 2023 Operator: Good day and welcome to the PacBio First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would […]
Insider Monkey12 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 12 gene editing stocks with the best long-term potential. To see more such companies, go directly to 5 Gene Editing Stocks With the Best Long-Term Potential. Gene editing stocks are gaining ground on the back of an upbeat tone in the industry, helped by a […]
